摘要
目的:对应用氨溴索佐治哮喘性支气管炎患者的临床价值进行分析。方法:对2012年4月∽2014年4月期间在某院接受治疗的80例哮喘性支气管炎患者进行临床研究,随机分为对照组和研究组,对对照组进行常规治疗,对研究组进行常规治疗加氨溴索治疗,比较两组的临床效果。结果:研究组哮喘性支气管炎患者的治疗总有效率明显高于对照组患者,且两组差异存在统计学上的意义(P〈0.05),两组患者均没有表现出比较严重的不良反应情况;研究组患者的症状及体征(咳嗽、痰鸣、喘息、湿啰音、哮鸣音)消失的时间明显短于对照组,两组差异存在统计学上的意义(P〈0.05)。结论:使用氨溴索辅佐治疗哮喘性支气管炎患者的效果较好,可降低患者的症状及体征消失时间,具有一定的临床价值。
Objective:To analyze the clinical value of ambroxol in treatment of asthmatic bronchitis.Meth-ods:Select 80 cases of patients with asthmatic bronchitis received during the period from April 2012 to April 2014 and make clinical research on them.Randomly divide them into the control group and the study group. Treat the control group with conventional treatments and the study group with ambroxol along with conven-tional treatments.Compare the clinical effect of the two groups.Results:The total effective rate of the study group group was obviously higher than that of the control group,and the difference between the two group was statistically significant(P<0.05).None of the patients in both group showed any serious adverse reac-tion.Compared with the control group,signs and symptoms like cough ,wheezy phlegm,gasp,rale and wheezing disappeared earilier in the study group.The difference was statistically significant.Conclusion:It is effective to treat the asthmatic bronchitis with the adj uvant of ambroxol,thus patients'symptoms and signs would disappear earlier.It is clinically valuable.
出处
《数理医药学杂志》
2015年第3期396-397,共2页
Journal of Mathematical Medicine